Published in AIDS Weekly, October 11th, 1999
Prozei was approved in mid-September 1999 through a new fast-track evaluation process instituted by the Japanese Ministry of Health and Welfare for innovative HIV therapies, and the drug was to be available to patients beginning October 1.
Prozei (known outside of Japan by the trade name Agenerase) was discovered at Vertex and has been developed in Japan by Kissei. Prozei is indicated in combination with other...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.